SUBSCRIBE
SUBSCRIBE
News   Drug Development

Puma Biotech Reports First Quarter 2016 Financial Results

May 11, 2016 | 
1 min read
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2016.

Unless otherwise stated, all comparisons are for the first quarter 2016 compared to the first quarter 2015.
Clinical research Phase III Earnings
MORE ON THIS TOPIC
Novartis' office building in Marburg, Germany
Tariffs
Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in US as Tariffs Near
July 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Exclusive magazine sketch collage image of happy businesswoman businessman stand question mark strategy ceo magnifier search job.
Neuropsychiatric disorders
Otsuka, Lundbeck’s PTSD Bid for Rexulti Hits Speedbump as FDA Questions Efficacy
July 17, 2025
 · 
2 min read
 · 
Tristan Manalac
IN PARTNERSHIP WITH EVOTEC
Webinar: Pharma Industry in Crisis
July 16, 2025
 · 
1 min read
 · 
BioSpace Insights
Goal disorientation and lack of vision. Inability to set the right business objectives. Failure to achieve the objectives. Missing the unrealistic and inaccurate company goals.
Rare diseases
AstraZeneca’s Amyloidosis Asset Stumbles in Late-Stage Trials
July 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky